feed,title,long_url,short_url
MedRxiv,In Silico Molecular-Based Rationale for SARS-CoV-2 Spike Circulating Mutations Able to Escape Bamlanivimab and Etesevimab Monoclonal Antibodies,https://biorxiv.org/cgi/content/short/2021.05.18.444605v1?rss=1,https://j.mp/3uUrRF7
